SCHEMBL8043219

SCHEMBL8043219

CCCc1cc(C(=O)OCC)n(C(C)C)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.41
POLB P06746 5/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
GABRA1 P14867 2/20 0.38
GABRB2 P47870 2/20 0.38
CYP11B1 P15538 2/20 0.38
CYP11B2 P19099 2/20 0.38
LMNA P02545 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ABCB11 O95342 1/20 0.38
GABRA2 P47869 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12410988 0.82 SMN1; SMN2 (0.47) TSHRPOLBCYP1A2CYP3A4GABRA1
SCHEMBL859 0.81 POLB (0.50) POLBLMNAHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL6734669 0.81 CYP1A2 (0.44) TSHRPOLBCYP1A2CYP3A4GABRA1
SCHEMBL25435175 0.81 ALDH1A1 (0.41) TSHRPOLBCYP1A2CYP3A4GABRA1
SCHEMBL1299 0.81 SMN1; SMN2 (0.45) TSHRPOLBSMN1; SMN2ALDH1A1MAPT
SCHEMBL23754103 0.79 TSHR (0.40) TSHRPOLBCYP1A2CYP3A4GABRA1
SCHEMBL25033914 0.79 ADORA3 (0.43) TSHRPOLBCYP1A2CYP3A4GABRA1
SCHEMBL15273783 0.78 HTR2C (0.43) TSHRPOLBCYP1A2CYP3A4GABRA1
SCHEMBL6360335 0.77 POLB (0.42) TSHRPOLBLMNAHSD17B10SMN1; SMN2
SCHEMBL4419031 0.77 GRN (0.42) TSHRPOLBCYP1A2CYP3A4GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071707-A1 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed